{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:09:15Z","timestamp":1788883755600,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.clinre.2014.07.012","type":"journal-article","created":{"date-parts":[[2014,8,28]],"date-time":"2014-08-28T14:10:56Z","timestamp":1409235056000},"page":"107-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Histological inflammation in ulcerative colitis in deep remission under treatment with infliximab"],"prefix":"10.1016","volume":"39","author":[{"given":"Antonio","family":"Tursi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Elisei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Picchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Forti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Penna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosimo Damiano","family":"Inchingolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Nenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Brandimarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2014.07.012_bib0005","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.crohns.2011.11.001","article-title":"Recommendations for the treatment of ulcerative colitis with infliximab: a gastroenterology expert group consensus","volume":"6","author":"Reinisch","year":"2012","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.clinre.2014.07.012_bib0010","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.crohns.2011.06.009","article-title":"Results from the 2nd scientific workshop of the ECCO. I: impact of mucosal healing on the course of inflammatory bowel disease","volume":"5","author":"Peyrin-Biroulet","year":"2011","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.clinre.2014.07.012_bib0015","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1053\/j.gastro.2009.06.061","article-title":"Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab","volume":"137","author":"Sandborn","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2014.07.012_bib0020","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1056\/NEJMcibr0707718","article-title":"Inflammatory bowel disease\u2013live transmission","volume":"358","author":"Hecht","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2014.07.012_bib0025","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/MIB.0b013e3182802909","article-title":"Infliximab in steroid-dependent ulcerative colitis: effectiveness and predictors of clinical and endoscopic remission","volume":"19","author":"Armuzzi","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clinre.2014.07.012_bib0030","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1053\/j.gastro.2006.12.038","article-title":"A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis","volume":"132","author":"D\u2019Haens","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2014.07.012_bib0035","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1159\/000338139","article-title":"Treat the patient or treat the disease?","volume":"30","author":"Hanauer","year":"2012","journal-title":"Dig Dis"},{"key":"10.1016\/j.clinre.2014.07.012_bib0040","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/BF02233941","article-title":"Serial rectal biopsy in ulcerative colitis during the course of a controlled therapeutic trial of various diets","volume":"11","author":"Wright","year":"1966","journal-title":"Am J Dig Dis"},{"key":"10.1016\/j.clinre.2014.07.012_bib0045","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1053\/gast.2001.20912","article-title":"Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis","volume":"120","author":"Bitton","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2014.07.012_bib0050","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1136\/gut.32.2.174","article-title":"Microscopic activity in ulcerative colitis: what does it mean?","volume":"32","author":"Riley","year":"1991","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2014.07.012_bib0055","first-page":"A19","article-title":"Increased degree of histological inflammation predicts colectomy and hospitalization in patients with ulcerative colitis","volume":"132","author":"Rubin","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2014.07.012_bib0060","doi-asserted-by":"crossref","first-page":"A133","DOI":"10.1136\/gut.2011.239301.282","article-title":"Depth of remission may not predict outcome of UC over 2 years","volume":"60","author":"Burger","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2014.07.012_bib0065","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/ibd.21925","article-title":"Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammation","volume":"18","author":"Baars","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clinre.2014.07.012_bib0070","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/MIB.0b013e3182802b0e","article-title":"Predictors of endoscopic inflammation in patients with ulcerative colitis in clinical remission","volume":"19","author":"Rosenberg","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clinre.2014.07.012_bib0075","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.cgh.2013.02.030","article-title":"Histologic markers of inflammation in patients with ulcerative colitis in clinical remission","volume":"11","author":"Rosenberg","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2014.07.012_bib0080","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.dld.2007.06.003","article-title":"Tumour necrosis factor-alpha down-regulation parallels inflammatory regression in ulcerative colitis patients treated with infliximab","volume":"39","author":"Hassan","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clinre.2014.07.012_bib0085","first-page":"147","article-title":"Ultrastructural evidence of mucosal healing after infliximab in patients with ulcerative colitis","volume":"19","author":"Fratila","year":"2010","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1016\/j.clinre.2014.07.012_bib0090","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/gut.47.3.404","article-title":"A reproducible grading scale for histological assessment of inflammation in ulcerative colitis","volume":"47","author":"Geboes","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2014.07.012_bib0095","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","article-title":"Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis: a randomised study","volume":"317","author":"Schroeder","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2014.07.012_bib0100","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/0161-5890(93)90106-L","article-title":"Construction and initial characterization of a mouse-human chimeric anti-TNF-antibody","volume":"30","author":"Knight","year":"1993","journal-title":"Mol Immunol"},{"key":"10.1016\/j.clinre.2014.07.012_bib0105","doi-asserted-by":"crossref","first-page":"968","DOI":"10.3748\/wjg.v19.i7.968","article-title":"Histological healing in inflammatory bowel disease: a still unfulfilled promise","volume":"19","author":"Villanacci","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinre.2014.07.012_bib0110","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/ibd.20997","article-title":"Importance of mucosal healing in ulcerative colitis","volume":"16","author":"Lichtenstein","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clinre.2014.07.012_bib0115","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/01.MIB.0000437986.00190.71","article-title":"Histologic evaluation of ulcerative colitis: a systematic review of disease activity indices","volume":"20","author":"Mosli","year":"2014","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/j.clinre.2014.07.012_bib0120","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.cgh.2013.07.022","article-title":"Histologic remission: the ultimate therapeutic goal in ulcerative colitis?","volume":"12","author":"Peyrin-Biroulet","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2014.07.012_bib0125","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.crohns.2012.10.018","article-title":"Achievement of deep remission during scheduled maintenance therapy with TNF\u03b1-blocking agents in IBD","volume":"7","author":"Molander","year":"2013","journal-title":"J Crohns Colitis"},{"issue":"Suppl. 3","key":"10.1016\/j.clinre.2014.07.012_bib0130","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000342732","article-title":"Deep remission: a new concept?","volume":"30","author":"Colombel","year":"2012","journal-title":"Dig Dis"},{"key":"10.1016\/j.clinre.2014.07.012_bib0135","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/ibd.22839","article-title":"Ulcerative colitis as a progressive disease: the forgotten evidence","volume":"18","author":"Torres","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clinre.2014.07.012_bib0140","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/MIB.0b013e318280e75f","article-title":"Correlation between the endoscopic and histologic score in assessing the activity of ulcerative colitis","volume":"19","author":"Lemmens","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.clinre.2014.07.012_bib0145","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000331683","article-title":"Endoscopic surveillance in Crohn's disease and ulcerative colitis: who needs what and when?","volume":"29","author":"Baumgart","year":"2011","journal-title":"Dig Dis"},{"key":"10.1016\/j.clinre.2014.07.012_bib0150","first-page":"1275","article-title":"Patchy cecal inflammation associated with distal ulcerative colitis: a prospective endoscopic study","volume":"92","author":"D\u2019Haens","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinre.2014.07.012_bib0155","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00054725-200405000-00006","article-title":"The clinical significance of right-sided colonic inflammation in patients with left-sided chronic ulcerative colitis","volume":"10","author":"Mutinga","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clinre.2014.07.012_bib0160","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/gut.2005.069476","article-title":"Laboratory markers in IBD: useful, magic, or unnecessary toys?","volume":"55","author":"Vermeire","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2014.07.012_bib0165","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.MIB.0000173271.18319.53","article-title":"Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease","volume":"11","author":"Solem","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clinre.2014.07.012_bib0170","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00384-006-0159-9","article-title":"Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease","volume":"22","author":"D\u2019Inc\u00e0","year":"2007","journal-title":"Int J Colorectal Dis"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740114001752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740114001752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:38:40Z","timestamp":1788881920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740114001752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S2210740114001752"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2014.07.012","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histological inflammation in ulcerative colitis in deep remission under treatment with infliximab","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2014.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}